N-Fmoc-N'-piperazinylcarbonyl-L-ornithine is a protected derivative of the non-proteinogenic amino acid L-ornithine. Its structure features an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group, which is standard for solid-phase peptide synthesis (SPPS), and a piperazinecarboxamide moiety attached to the side-chain amino group. This specific modification makes it a specialized building block. This compound is primarily used as a key intermediate in the synthesis of complex peptides and peptidomimetics. The piperazine moiety introduces a basic, nitrogen-rich heterocycle into the peptide backbone or side chain, which can be crucial for enhancing solubility, modifying pharmacokinetic properties, or serving as a scaffold for further functionalization in drug discovery. It is particularly valuable in medicinal chemistry research for developing novel therapeutic agents. As a non-natural, protected amino acid derivative, it is a high-value research chemical supplied for laboratory use in pharmaceutical development. Handling requires standard precautions for laboratory chemicals, and it should be stored under appropriate conditions to maintain stability.